Answers are grounded in this paper and cite their sources.
Updated systematic review reports functional recovery in acute ischemic stroke, suggesting effective treatment options.
Edaravone-Dexborneol might be an effective treatment for improving functional recovery in patients with AIS and appears to have a relatively favorable safety profile. However, careful dosing is necessary to minimize AEs. Future research should focus on large-scale trials, long-term outcomes, and mechanistic studies to optimize treatment protocols.
No takes yet. Share an insight, caveat, or question.
Sabet et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: